Mind Medicine (MindMed) Inc.

MNMD
$44.95 (+ $0.16 + 0.36%)
Last updated: 2026-07-03 19:16 UTC
MNMD Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINCA60255C1095
Market Price44.95
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend Frequency N/A
P/E RatioN/A
EPS-1.98
Market Cap$1.3B
Book Value1.7
Price to Book7.895
Beta2.8
52w High14.43
52w Low4.7
Next Earnings DateN/A

Mind Medicine (MindMed) Inc. trades under ticker MNMD on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN CA60255C1095. Also searched as Mind Medicine (MindMed).

Related researchMNMD stock priceMNMD share priceMind Medicine (MindMed) stockMind Medicine (MindMed) share price
About the Company
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
Price History